532834 Stock Overview
Engages in the research, development, manufacture, and marketing of specialty chemicals, ingredients, and additive blend products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Camlin Fine Sciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹130.05 |
| 52 Week High | ₹139.50 |
| 52 Week Low | ₹80.00 |
| Beta | 0.90 |
| 1 Month Change | 8.42% |
| 3 Month Change | 26.02% |
| 1 Year Change | -3.24% |
| 3 Year Change | 9.47% |
| 5 Year Change | 54.64% |
| Change since IPO | 1,430.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532834 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 5.4% | -4.7% | -4.2% |
| 1Y | -3.2% | 4.7% | 19.4% |
Return vs Industry: 532834 underperformed the Indian Chemicals industry which returned 4.7% over the past year.
Return vs Market: 532834 underperformed the Indian Market which returned 19.4% over the past year.
Price Volatility
| 532834 volatility | |
|---|---|
| 532834 Average Weekly Movement | 6.4% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 532834 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 532834's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1931 | 624 | n/a | www.camlinfs.com |
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include antioxidants comprises Butylated Hydroxy Toluene and Ascorbyl palmitate; and emulsifiers, mold inhibitors, antibacterial agents, toxin binders, pellet binders, disinfectants, energizers, preservatives, thickening agents, and growth promoters, as well as plant-based antioxidants, such as mixed tocopherols, green tea extract, and rosemary extract that are used to enhance the shelf life under the Xtendra and NaSure brands. It also provides aroma ingredients, including vanillin and ethyl vanillin; health and wellness products; and performance chemicals, such as hydroquinone and catechol.
Camlin Fine Sciences Limited Fundamentals Summary
| 532834 fundamental statistics | |
|---|---|
| Market cap | ₹21.28b |
| Earnings (TTM) | -₹2.23b |
| Revenue (TTM) | ₹16.06b |
1.4x
P/S Ratio-9.8x
P/E RatioIs 532834 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532834 income statement (TTM) | |
|---|---|
| Revenue | ₹16.06b |
| Cost of Revenue | ₹9.50b |
| Gross Profit | ₹6.57b |
| Other Expenses | ₹8.80b |
| Earnings | -₹2.23b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -13.32 |
| Gross Margin | 40.89% |
| Net Profit Margin | -13.89% |
| Debt/Equity Ratio | 111.2% |
How did 532834 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 15:04 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Camlin Fine Sciences Limited is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ankur Periwal | Axis Capital Limited |
| Satish Kumar | CGS International |
| null null | DBS Bank Ltd |